Table 1 Characteristics of participants at baseline*.

From: Improving medication adherence in adult kidney transplantation (IMAKT): A pilot randomised controlled trial

Characteristics

Total

N = 71

Control

n = 36

Intervention

n = 35

Gender

Male

41 (57.7)

19 (52.8)

22 (62.9)

Prior dialysis

Yes

61 (85.9)

33 (91.7)

28 (80.0)

Type of transplant

Deceased

50 (70.4)

23 (63.9)

27 (77.1)

Highest level of education

Secondary

29 (40.8)

15 (41.7)

14 (40.0)

Tertiary

42 (59.2)

21 (58.3)

21 (60.0)

Support at home

Yes

61 (85.9)

34 (94.4)

27 (77.1)

Continent of birth

Australia and Oceania

42 (59.2)

19 (52.8)

23 (5.7)

Asia

18 (25.4)

13 (36.1)

5 (14.3)

Europe

8 (11.3)

3 (±8.3)

5 (14.3)

Africa

3 (4.2)

1 (2.8)

2 (5.7)

Abbreviated Mental Test Score

10

53 (74.6)

25 (69.4)

28 (80.0)

9

15 (21.1)

8 (22.2)

7 (20.0)

6–8

3 (4.2)

3 (8.4)

0 (0.0)

Age

Age years [Mean (SD)]

51.0 (11.4)

48.4 (11.1)

53.6 (11.3)

Age range

23–74

23–66

32–74

Time since transplant, days [median (IQR)]

28.0

(20.3, 41.0)

27.0

(19.3, 39.5)

29.0

(21.0, 43.0)

  1. *Data are numbers (%), means (SD) or median (IQR).